|
|
|
|
Evaluation of Paraoxonase Activity in Children With Nephrotic Syndrome
|
|
|
|
|
|
|
|
نویسنده
|
Hashemi Mohammad ,Sadeghi-Bojd Simin ,Raeisi Mohsen ,Moazeni-Roodi Abdolkarim
|
|
منبع
|
nephro-urology monthly - 2013 - دوره : 5 - شماره : 5 - صفحه:978 -982
|
|
چکیده
|
Background: it has been proposed that reactive oxygen species (ros) is involved in the pathogenesis of various diseases. paraoxonase, a high-density lipoprotein associated enzyme, prevents low-density lipoproteins from oxidation. objectives: the aim of the present study was to investigate the serum activities of paraoxonase-1 (pon-1), and aryleterase (are) as well as total antioxidant capacity (tac) in children with nephrotic syndrome in acute and remission phase. patients and methods: the study consisted of 20 patients in acute and remission phases and 23 healthy controls. pon-1 and are activities were determined spectrophotometrically using paraoxone and phenyacetate as substrate, respectively. tac was measured using ferric reducing ability of plasma (frap). results: the levels of pon, are, and tac were significantly lower in acute phase of nephrotic syndrome compared with the remission phase. the levels of pon, are and tac increased in remission phase. conclusions: our results revealed that the determination of paraoxonase activity might be a biomarker for responses to nephrotic syndrome treatment, which needs to be fully clarified.
|
|
کلیدواژه
|
Nephrotic Syndrome; Aryldialkylphosphatase; Antioxidants
|
|
آدرس
|
zahedan university of medical sciences, School of Medicine, Cellular and Molecular Research Center, Department of Clinical Biochemistry, ایران, zahedan university of medical sciences, School of Medicine, Research Center for Children and Adolescents Health, Department of Pediatrics, ایران, zahedan university of medical sciences, School of Medicine, Department of Pediaterics, ایران, zahedan university of medical sciences, Cellular and Molecular Research Center, ایران
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|